This table provides the postoperative TEG® PM™ measurements for both the PR and SR groups. These measurements include G, TEG® MA, MA Activator, ADP MA, AA MA, ADP Inhibition, AA Inhibition, ADP Aggregation, AA Aggregation.

Parameter

PR Group (n=12)

SR Group (n=11)

P value

Mean

Median

Mean

Median

G (K dynes/cm2)

12.2 ± 5.90

10.9 [9.7, 15.1]

11.9 ± 3.73

13.4 [9.8, 14.4]

0.94

TEG® MA (mm)

71.9 ± 5.66

72.1 [67.5, 75]

68.7 ± 7.88

70.5 [66.3, 73.9]

0.60

MA Activator (mm)

9.4 ± 4.15

9.5 [8.1, 9.8]

9.9 ± 8.95

7.9 [4.9, 9.9]

0.47

ADP MA (mm)

51.7 ± 15.58

54.3 [43.1, 65.1]

55.1 ± 9.20

54.9 [51.1, 61.2]

0.86

AA MA (mm)

57.7 ± 19.28

64.1 [52.8, 68.4]

57.1 ± 16.32

63.7 [50.7, 67.8]

0.81

ADP Inhibition (%)

29.7 ± 21.81

24.8 [14.4, 43.9]

22.1 ± 15.09

20.5 [13.4, 30.4]

0.39

AA Inhibition (%)

24.3 ± 25.98

18.1 [11.2, 27.9]

19.5 ± 23.19

9.7 [5.0, 29.7]

0.56

ADP Aggregation (%)

0.7 ± 0.22

0.8 [0.6, 0.9]

0.8 ± 0.16

0.8 [0.7, 0.9]

0.45

AA Aggregation (%)

0.8 ± 0.26

0.8 [0.7, 0.9]

0.8 ± 0.23

0.9 [0.7, 1.0]

0.57

Data are presented as mean ± SD and median [1st Quartile, 3rd Quartile]. Two-tailed P value determined using Mann-Whitney U test. There were no statistically significant differences between the two groups. SD = Standard Deviation; PR = propofol/ remifentanyl; SR = sevoflurane/remifentanyl.
Table 3b: Postoperative TEG® PM™ Data.